Advertisements

Stocking Stuffers

 

Knight Therapeutics Inc. (GUD:CA) Stock Quote

Detailed Quote for Knight Therapeutics Inc. (GUD:CA)
$ 7.62   0.06 (+0.79%) Volume: 173.59k 4:00 PM EST Dec 13, 2019
Today 5d 1m 3m 1y more
Last Price
7.62
Change $
0.06
Change %
0.79%
Tick
  
Bid
7.60
Bid Size
1,000
Ask
7.63
Ask Size
500
Open
7.55
High
7.65
Low
7.55
Prev Close
7.56
Last Trade
12/13/19
Volume
173.59k
52 Wk Hi
8.88000011
52 Wk Low
7.0999999
Market Cap
1.03b
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
135,629,136
EPS (TTM)
0.159999996
PE Ratio
48.80
Exchange
TSX
News and Media for Knight Therapeutics Inc. (GUD:CA)
Sector News | Topic News
News for Knight Therapeutics Inc. (GUD:CA)
Fri, Nov 29, 2019
5:00 PM Knight Therapeutics Announces Closing of Previously Announced Acquisition of Grupo Biotoscana - GlobeNewswire
Tue, Nov 26, 2019
7:30 AM Knight and TherapeuticsMD Announce Filing of New Drug Submission for\u00A0Bijuva\u00AE\u00A0in Canada - GlobeNewswire
Mon, Nov 25, 2019
4:15 PM Profound Medical Announces Health Canada Approval of TULSA-PRO\u00AE - GlobeNewswire
Thu, Nov 21, 2019
5:00 PM GUD Medison Resolved - GlobeNewswire
Tue, Nov 12, 2019
5:22 PM Knight Therapeutics Reports Third Quarter 2019 Results - GlobeNewswire
Tue, Nov 05, 2019
7:30 AM Notice of Knight Therapeutics' Third Quarter 2019 Results Conference Call - GlobeNewswire
Wed, Oct 30, 2019
5:05 PM Knight and TherapeuticsMD Announce Filing of New Drug Submission for Joyesta(TM) in Canada - Business Wire
5:01 PM Knight and TherapeuticsMD Announce Filing of New Drug Submission for\u00A0Joyesta(TM) in Canada - GlobeNewswire
Wed, Oct 23, 2019
7:00 AM Knight Therapeutics and SIFI S.p.A. Announce Approval of NETILDEX(TM) in Canada - GlobeNewswire
Mon, Oct 21, 2019
7:00 AM Knight Therapeutics to Acquire Grupo Biotoscana, Establishing a Latin American Growth Platform - GlobeNewswire
Tue, Sep 03, 2019
2:37 PM Medison Urges Knight Therapeutics and Jonathan Goodman to Aggressively Pursue Opportunities Created by Distressed Opioid Case Targets - Business Wire
Mon, Aug 26, 2019
8:00 AM Israeli Courts Rule Against Knight Therapeutics' and Jonathan Goodman in Frivolous and Costly Litigation Aimed at Silencing Medison - Business Wire
Fri, Aug 09, 2019
8:00 AM Medison Expresses Concerns over Knight Therapeutics' Second Quarter Results and Demands Answers to Critical Questions from Jonathan Goodman - Canada Newswire
Thu, Aug 08, 2019
6:00 AM Knight Therapeutics Reports Second Quarter 2019 Results - GlobeNewswire
Tue, Aug 06, 2019
8:30 AM Knight Therapeutics and pan-Canadian Pharmaceutical Alliance (pCPA) Reach Agreement for PROBUPHINE\u00C2\u00AE for Opioid Dependence - GlobeNewswire
8:30 AM Knight Announces Early Warning Filing Regarding Disposition of Shares of Crescita - GlobeNewswire
Thu, Aug 01, 2019
8:30 AM Notice of Knight Therapeutics' Second Quarter 2019 Results Conference Call - GlobeNewswire
Thu, Jul 18, 2019
8:00 AM Medison Biotech Considers Requisition of Special Meeting of Shareholders of Knight Therapeutics Inc. - Business Wire
Tue, Jul 16, 2019
4:30 PM Knight Therapeutics Announces Health Canada Has Approved\u00A0NERLYNX \u00AE for Early-Stage Breast Cancer - GlobeNewswire
Tue, Jul 09, 2019
8:41 AM Medison Biotech: Jonathan Goodman Takes Advantage of His Own Failure to Create Value, Enriching Himself at the Expense of the Shareholders of Knight Therapeutics - Business Wire
More News for GUD:CA >>

Tags for Knight Therapeutics Inc.

Research stocks or mutual funds related to Knight Therapeutics Inc. by keywords or tags. Find companies that have a similar focus to GUD:CA. The keywords below have been associated to GUD:CA by either user submission or electronic means.